Alkeus Pharmaceuticals Funding: $160M Raised, Series B
Alkeus Pharmaceuticals is based in Cambridge. It has raised $160M in total funding. Latest round: Series B.
Alkeus Pharmaceuticals funding overview
Alkeus Pharmaceuticals is based in Cambridge. Alkeus Pharmaceuticals has raised $160M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in June 2023. The round record for Alkeus Pharmaceuticals runs through 2023; nothing later has been disclosed. Investors on record include Bain Capital Life Sciences, TCGX, Wellington Management, Sofinnova Investments. 4 distinct backers are named across the disclosed rounds.
Alkeus Pharmaceuticals at a glance
Total raised
$160M
Latest round
Series B
Latest round date
June 2023
Headquarters
Cambridge
Notable investors
Bain Capital Life Sciences, TCGX, Wellington Management, Sofinnova Investments
Frequently asked about Alkeus Pharmaceuticals funding
How much has Alkeus Pharmaceuticals raised?
Alkeus Pharmaceuticals has raised $160M in total disclosed funding across the rounds on record.
Who has invested in Alkeus Pharmaceuticals?
Bain Capital Life Sciences, TCGX, Wellington Management, Sofinnova Investments are named among the investors backing Alkeus Pharmaceuticals.
What was the latest Alkeus Pharmaceuticals funding round?
The most recent disclosed round is a Series B, announced in June 2023.
Where is Alkeus Pharmaceuticals based?
Alkeus Pharmaceuticals is based in Cambridge.
When did Alkeus Pharmaceuticals last raise?
The last disclosed Alkeus Pharmaceuticals round closed in June 2023 at Series B.
Totals shown for Alkeus Pharmaceuticals aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.
